Clever Leaves Becomes GMP Certified by INVIMA

The vertically integrated Colombian licensed producer's practices are now in line with other global pharmaceutical companies.

BOGOTÁ, Colombia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Clever Leaves, a vertically-integrated Colombian licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has become authorized by the Colombian National Food and Drug Surveillance Institute (Instituto Nacional de Vigilancia de Medicamentos y Alimentos or INVIMA) to be Good Manufacturing Practices (GMP) certified to produce medical cannabis. GMP certification by INVIMA allows Clever Leaves to produce phytotherapeutic medicines derived from cannabis which can be prescribed through a medical distribution channel.

“This is a crucial milestone for the medical cannabis industry in Colombia. GMP certification by INVIMA demonstrates that the industry is achieving pharmaceutical-grade standards recognized by regulators throughout the world. This step forward allows us to enhance our positioning as a leading medical cannabis producer and is the result of more than a year of effort, discipline and dedication of a highly qualified work team committed to the health of patients globally,” said Andres Fajardo, CEO of Clever Leaves.

“Obtaining GMP certification from INVIMA underscores Clever Leaves’ competitive advantages and status as an industry leader in the global cannabis market. INVIMA’s GMP certification is formal recognition of Clever Leaves’ operational excellence and adherence to international pharmaceutical standards. In a rapidly-emerging industry where patients and regulators have a lack of internationally-recognizable quality standards on which to rely, GMP certification is a difficult-to-obtain but easy-to-recognize symbol of quality,” said Kyle Detwiler, CEO of Northern Swan Holdings, Inc., the financial sponsor and strategic partner of Clever Leaves.

INVIMA is a regulatory agency within Colombia’s Ministry of Health. INVIMA is responsible for inspecting and supervising the marketing and manufacturing of health products, as well as providing medical approval for the import and export of various products. INVIMA performs many tasks which are akin to functions of the U.S. Food and Drug Administration (FDA). GMP certification from INVIMA is a quality assurance validation system which allows pharmaceutical distribution channels to evaluate the quality and safety of manufactured products and is generally considered to be a prerequisite in the process of obtaining final market authorization in highly regulated markets.

Since its founding in 2016, Clever Leaves has achieved a number of significant milestones which have established Colombia as a future leader of the industry, including the first export of dried flower to Canada for scientific research purposes as well as the first Colombian cannabidiol (CBD) product to the United Kingdom, and now GMP certification from a leading pharmaceutical regulatory agency.